207 related articles for article (PubMed ID: 27869201)
1. Cardioprotection by combination of three compounds from ShengMai preparations in mice with myocardial ischemia/reperfusion injury through AMPK activation-mediated mitochondrial fission.
Li F; Fan X; Zhang Y; Pang L; Ma X; Song M; Kou J; Yu B
Sci Rep; 2016 Nov; 6():37114. PubMed ID: 27869201
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms dissection of the combination GRS derived from ShengMai preparations for the treatment of myocardial ischemia/reperfusion injury.
Yang W; Lai Q; Zhang L; Zhang Y; Zhang Y; Yu B; Li F; Kou J
J Ethnopharmacol; 2021 Jan; 264():113381. PubMed ID: 32946961
[TBL] [Abstract][Full Text] [Related]
3. A Strategy for Optimizing the Combination of Active Components Based on Chinese Medicinal Formula Sheng-Mai-San for Myocardial Ischemia.
Li F; Fan XX; Chu C; Zhang Y; Kou JP; Yu BY
Cell Physiol Biochem; 2018; 45(4):1455-1471. PubMed ID: 29466787
[TBL] [Abstract][Full Text] [Related]
4. YiQiFuMai Powder Injection Attenuates Ischemia/Reperfusion-Induced Myocardial Apoptosis Through AMPK Activation.
Li F; Zheng X; Fan X; Zhai K; Tan Y; Kou J; Yu B
Rejuvenation Res; 2016 Dec; 19(6):495-508. PubMed ID: 27072567
[TBL] [Abstract][Full Text] [Related]
5. Calenduloside E Ameliorates Myocardial Ischemia-Reperfusion Injury through Regulation of AMPK and Mitochondrial OPA1.
Wang M; Wang RY; Zhou JH; Xie XH; Sun GB; Sun XB
Oxid Med Cell Longev; 2020; 2020():2415269. PubMed ID: 32934760
[TBL] [Abstract][Full Text] [Related]
6. YiXin-Shu, a ShengMai-San-based traditional Chinese medicine formula, attenuates myocardial ischemia/reperfusion injury by suppressing mitochondrial mediated apoptosis and upregulating liver-X-receptor α.
Zhao Y; Xu L; Qiao Z; Gao L; Ding S; Ying X; Su Y; Lin N; He B; Pu J
Sci Rep; 2016 Mar; 6():23025. PubMed ID: 26964694
[TBL] [Abstract][Full Text] [Related]
7. lncRNA Oip5-as1 inhibits excessive mitochondrial fission in myocardial ischemia/reperfusion injury by modulating DRP1 phosphorylation.
Niu X; Zhang J; Hu S; Dang W; Wang K; Bai M
Cell Mol Biol Lett; 2024 May; 29(1):72. PubMed ID: 38745296
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice.
Ding M; Dong Q; Liu Z; Liu Z; Qu Y; Li X; Huo C; Jia X; Fu F; Wang X
Cardiovasc Diabetol; 2017 Feb; 16(1):19. PubMed ID: 28173848
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of myosin IIA-actin interaction prevents ischemia/reperfusion induced cardiomyocytes apoptosis through modulating PINK1/Parkin pathway and mitochondrial fission.
Li F; Fan X; Zhang Y; Zhang Y; Ma X; Kou J; Yu B
Int J Cardiol; 2018 Nov; 271():211-218. PubMed ID: 30144997
[TBL] [Abstract][Full Text] [Related]
10. Extract of Sheng-Mai-San Ameliorates Myocardial Ischemia-Induced Heart Failure by Modulating Ca
Yang Y; Tian Y; Hu S; Bi S; Li S; Hu Y; Kou J; Qi J; Yu B
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841143
[TBL] [Abstract][Full Text] [Related]
11. Schisandrin B protects myocardial ischemia-reperfusion injury partly by inducing Hsp25 and Hsp70 expression in rats.
Chiu PY; Ko KM
Mol Cell Biochem; 2004 Nov; 266(1-2):139-44. PubMed ID: 15646035
[TBL] [Abstract][Full Text] [Related]
12. Salidroside attenuates myocardial ischemia/reperfusion injury via AMPK-induced suppression of endoplasmic reticulum stress and mitochondrial fission.
Tian X; Huang Y; Zhang X; Fang R; Feng Y; Zhang W; Li L; Li T
Toxicol Appl Pharmacol; 2022 Aug; 448():116093. PubMed ID: 35659894
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dynamics modulation as a critical contribution for Shenmai injection in attenuating hypoxia/reoxygenation injury.
Yu J; Li Y; Liu X; Ma Z; Michael S; Orgah JO; Fan G; Zhu Y
J Ethnopharmacol; 2019 Jun; 237():9-19. PubMed ID: 30880258
[TBL] [Abstract][Full Text] [Related]
14. Apigenin-7-O-β-d-(-6″-p-coumaroyl)-glucopyranoside pretreatment attenuates myocardial ischemia/reperfusion injury via activating AMPK signaling.
Feng Y; Lu Y; Liu D; Zhang W; Liu J; Tang H; Zhu Y
Life Sci; 2018 Jun; 203():246-254. PubMed ID: 29705352
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial Dysfunction and Apoptosis Are Attenuated on κ-Opioid Receptor Activation Through AMPK/GSK-3β Pathway After Myocardial Ischemia and Reperfusion.
Tian X; Zhou Y; Wang Y; Zhang S; Feng J; Wang X; Guo H; Fan R; Feng N; Jia M; Gu X; Li J; Yang L; Wang Y; Li J; Zheng G; Fu F; Pei J
J Cardiovasc Pharmacol; 2019 Feb; 73(2):70-81. PubMed ID: 30422891
[TBL] [Abstract][Full Text] [Related]
16. Exogenous NADPH ameliorates myocardial ischemia-reperfusion injury in rats through activating AMPK/mTOR pathway.
Zhu J; Wang YF; Chai XM; Qian K; Zhang LW; Peng P; Chen PM; Cao JF; Qin ZH; Sheng R; Xie H
Acta Pharmacol Sin; 2020 Apr; 41(4):535-545. PubMed ID: 31776448
[TBL] [Abstract][Full Text] [Related]
17. Schisandrol A Attenuates Myocardial Ischemia/Reperfusion-Induced Myocardial Apoptosis through Upregulation of 14-3-3
Gong S; Liu J; Wan S; Yang W; Zhang Y; Yu B; Li F; Kou J
Oxid Med Cell Longev; 2021; 2021():5541753. PubMed ID: 34257806
[TBL] [Abstract][Full Text] [Related]
18. Experimental diabetes mellitus exacerbates ischemia/reperfusion-induced myocardial injury by promoting mitochondrial fission: Role of down-regulation of myocardial Sirt1 and subsequent Akt/Drp1 interaction.
Tao A; Xu X; Kvietys P; Kao R; Martin C; Rui T
Int J Biochem Cell Biol; 2018 Dec; 105():94-103. PubMed ID: 30381241
[TBL] [Abstract][Full Text] [Related]
19. AMPK Contributes to Cardioprotective Effects of Pterostilbene Against Myocardial Ischemia- Reperfusion Injury in Diabetic Rats by Suppressing Cardiac Oxidative Stress and Apoptosis.
Kosuru R; Cai Y; Kandula V; Yan D; Wang C; Zheng H; Li Y; Irwin MG; Singh S; Xia Z
Cell Physiol Biochem; 2018; 46(4):1381-1397. PubMed ID: 29689567
[TBL] [Abstract][Full Text] [Related]
20. Penehyclidine hydrochloride regulates mitochondrial dynamics and apoptosis through p38MAPK and JNK signal pathways and provides cardioprotection in rats with myocardial ischemia-reperfusion injury.
Feng M; Wang L; Chang S; Yuan P
Eur J Pharm Sci; 2018 Aug; 121():243-250. PubMed ID: 29860115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
